Copyright © 2013, The Oklahoma Publishing Company
Through its Oklahoma Seed Capital Fund, i2E Inc. recently closed a $700,000 investment in Moleculera Labs Inc., which led a $1.84 million financing round in the Oklahoma City-based company.
The financing round also included investment by the i2E-managed SeedStep Angels and other angel investor groups. Moleculera Labs has developed a series of tests, the Cunningham Panel, that predicts a patient’s likelihood of having Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococci (PANDAS).
PANDAS are treatable neurological conditions that may be associated with motor tics, obsessive compulsive disorders and often associated with Autism Spectrum Disorders.
“This important financing round gives us the ability to help even more families, and to expand our services to meet the critical need for testing of these very sick children in the U.S. and worldwide,” said Dr. Craig Shimasaki, Moleculera co-founder and CEO.
The Oklahoma Seed Capital Fund is a state-appropriated investment fund that provides concept, seed and startup equity investments to Oklahoma high-growth businesses. The fund is managed by i2E through a collaboration with the Oklahoma Center for the Advancement of Science and Technology.
The SeedStep Angels group was founded by i2E in 2009 and now has chapters in Oklahoma City, Tulsa and Ardmore. Investments by SeedStep Angels members total more than $3.7 million since the group was founded.
From Staff Reports
